| Multiple Sclerosis: Epidemiology, Genetics and Environmental Factors (2007) | 
|  |
|
| The Future of Multiple Sclerosis Therapies (2006) |
| |
|
| Motivation in MS (2005) |
| |
|
| Neuroprotection in Multiple Sclerosis (2004) |
| |
|
| Early Management of Multiple Sclerosis (2003) |
| |
|
| Surrogate Markers of Clinical Disease in Multiple Sclerosis (2002) |
| |
|
| The Future of Clinical Trials in Multiple Sclerosis (2001) |
| |
|
| Pathology and Clinical Features of Multiple Sclerosis (2000) |
| |
|
| Clinicians and People with Multiple Sclerosis: Views on Multiple Sclerosis and its Management (1999) |
| |
|
| Mechanisms of Action and Clinical Effects of Beta Interferon in Multiple Sclerosis (1999) |
| |
|
| New Insights in Immunological Tolerance Mechanisms (1998) |
| |
|
| Environmental Factors in Multiple Sclerosis (1998) |
| |
|
| New Treatments for Multiple Sclerosis (1997) |
| |
|
| Imaging in Multiple Sclerosis (1997) |
| |
|
| Design and Interpretation of Clinical Trials in Multiple Sclerosis (1996) |
| |
|
| Biosynthesis of Myelin – Consequences for Remyelination Strategies (1996) |
| |
|
| Psychosocial Factors in Multiple Sclerosis (1995) |
| |
|
| Genetic Factors in Multiple Sclerosis (1995) |
| |
|
| Cytokine Networks in Multiple Sclerosis (1994) | 
| |
|
| The Symptoms of Multiple Sclerosis and their Management (1994) |
| |
|
| The Diagnosis of Multiple Sclerosis (1993) |
| |
|